Hematology and ASH Abstract Review

Hematology and ASH Abstract Reviews is planned and implemented by an interprofessional team of physicians, nurses, and pharmacists. This one-day course is designed for hematologists, oncologists, nurses, and pharmacists involved in the care of patients with hematologic and oncologic disorders and may also be of interest to other internal medicine subspecialists. The program will feature lectures, case discussions, expert panels, and interactive question-and-answer sessions highlighting key updates and best practices across malignant and benign hematology and medical oncology. The goal of this activity is to enhance participants knowledge, clinical strategies, and performance to improve patient outcomes.

Things to do in St. Louis this weekend!!

1. Apply current evidence and clinical research to the management of patients with benign and malignant hematologic disorders.
2. Incorporate emerging targeted, immunebased, cellular, and gene therapies into evidencebased treatment strategies for hematologic disorders.
3. Recognize and manage unique toxicities and adverse effects associated with newer therapies for hematologic disorders.

Registration will be available until Friday, January 15, 2027, 12:00pm CT.  After this time, please register on-site.

If you have any questions regarding the course or registration please contact Michelle Padgett at [email protected]

Fees includes enrollment, continuing education credits, educational materials, continental breakfast, lunch and refreshment breaks (paid registrants only).

*** IMPORTANT NOTE for Employees of industry (e.g., pharmaceutical & device companies): DO NOT REGISTER HERE. Please email [email protected] for pre-approval for attendance at this course. Should you register without pre-approval, your registration will be cancelled and refunded less a $25 administrative fee.

Registration/Payment Policy: Your full payment in advance completes your registration and ensures your enrollment in this course. 

Cancellations: Registration fee less $25 administrative charge is refundable if cancellation is received in writing by emailing [email protected] by January 7, 2027. Registration fees are not transferable.

Minimum and Maximum Enrollments Have Been Established.

General Information

Course Information:  Wednesday night prior to the course, an email with directions to the online syllabus and onsite information will be sent to the email address utilized to register for the event.

In support of improving patient care, Washington University School of Medicine in St. Louis is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credits Available for this Activity:

American Medical Association (AMA)
Washington University School of Medicine in St. Louis designates this live activity for a maximum of 6 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Nurses Credentialing Center (ANCC)
Washington University School of Medicine in St. Louis designates this live activity for a maximum of 6 ANCC contact hours.

Accreditation Council for Pharmacy Education (ACPE)
This activity is approved for a maximum of 6 knowledge-based contact hours (.6 CEUs) in states that recognize ACPE. Participants should only claim credit commensurate with the extent of their participation in the activity. Unique Universal Activity Number JA0000340-0000-27-002-L01-P.  To be awarded credit, attendees must sign in, provide their NABP ePID number and date of birth.

American Board of Internal Medicine Maintenance of Certification (ABIM MOC II)
Successful completion of the CME activity, which includes participation in the evaluation component, enables the participant to earn up to 6 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC Credit.

Interprofessional Continuing Education (IPCE)
This activity was planned by and for the healthcare team, and learners will receive 6 Interprofessional Continuing Education (IPCE) credits for learning and change.

Cancellation Policy

The cancellation cut-off dates and fees are specific to each course. Refer to the cancellation policy on the individual course page. Please send cancellation requests to [email protected].

WashU Medicine CME reserves the right to cancel or postpone this program if necessary; in the event of cancellation, course fees will be fully refunded. We are not responsible for other costs incurred, such as non-refundable airline tickets or hotel penalties.

Accessibility Statement

This meeting is conducted in accordance with the requirements of the Americans with Disabilities Act (ADA) and applicable regulations.
Individuals who require accommodations to participate are encouraged to submit a written request as early as possible, but no later than ten (10) business days prior to the seminar date, to allow sufficient time to arrange appropriate accommodations. Requests received after this deadline will be reviewed and a good faith effort will be made to provide reasonable accommodations to the extent feasible.

Course Hotel Accommodations: 
Make your hotel reservations directly with the hotel.

The discounted hotel block is available through Friday, December 18, 2026. 

Room Rate: ($329+tax) per night, based upon availability

The Ritz-Carlton - St. Louis
100 Carondelet Plaza
St. Louis, MO 63105

314-863-6300

You can reserve your room by visiting: 
Book your group rate for WashU CME Advances Meeting

Call 1-800-960-7056 and speak with a reservation agent mentioning the group name or code HWU.

Guests can also book through http://www.ritzcarlton.com/en/hotels/st-louis and use the code HWUHWUA for a King Bed, or HWUHWUH for a room with two Queen Beds.

Please Note: Washington University is not responsible for airline, hotel reservations or any other travel expenses. Please confirm registration acceptance prior to purchase of non-refundable or penalty airline tickets.

Transportation:
•    Taxis from the airport are approximately $40.
•    Uber and Lyft are also available.    

Washington University School of Medicine in St. Louis School of Medicine adheres to ACCME Criteria, Standards and Policies regarding industry support of continuing medical education. Disclosure of faculty and their commercial relationships will be made prior to the activity.

Mitigation of Relevant Financial Relationships

Washington University School of Medicine in St. Louis adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including Faculty, planners, reviewers, or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Member Information

Role in activity

Nature of Relationship(s) / Name of Ineligible Company(s)

Meagan A. Jacoby, MD
Professor of Medicine Section of Medical Oncology
WashU Medicine
St. Louis, MO

Course Director, Faculty

Grant or research support-Agios Pharmaceuticals|Grant or research support-Amphivena Therapeutics Inc|Grant or research support-Aprea Therapeutics AB|Grant or research support-AstraZeneca Pharmaceuticals LP|Grant or research support-Celgene Corporation|Grant or research support-Jazz Pharmaceuticals|Grant or research support-Kura Oncology|Grant or research support-Taiho Oncology Inc

Morey A. Blinder, MD
Professor of Medicine, Division of Hematology Associate Professor of Pathology & Immunology
WashU Medicine
St. Louis, MO

Faculty

Other relevant financial or material interests-Disc Medicine (*)|Other relevant financial or material interests-Recordati (*)|Other relevant financial or material interests-Sanofi US Services Inc (*)

Zachary D. Crees, MD
Assistant Professor of Medicine; Assistant Clinical Director, Center for Gene and Cellular Immunotherapy (CGCI)
WashU Medicine
St. Louis, MO

Faculty

Other relevant financial or material interests-A2 Biotherapeutics (*)|Other relevant financial or material interests-Ayrmid, Ltd. (*)|Other relevant financial or material interests-Bluebird Bio (*)|Other relevant financial or material interests-Gamida Cell (*)|Other relevant financial or material interests-Vertex (*)|Grant or research support-ASH Research Collaborative|Grant or research support-NeoImmuneTech|Grant or research support-OrcaBio|Grant or research support-Umoja Biopharma|Grant or research support-Kite Pharma Inc|Grant or research support-BioLineRx Ltd|Grant or research support-Bluebird Bio|Grant or research support-Cures Within Reach|Grant or research support-Cogent Biosciences

Brad S. Kahl, MD
Professor of Medicine, Division of Oncology Director, Lymphoma Program
WashU Medicine
St. Louis, MO

Faculty

Grant or research support-Acerta Pharma LLC|Other relevant financial or material interests-AstraZeneca (*)|Other relevant financial or material interests-BeOne Medicines (formerly BeiGene Ltd)|Speakers Bureau-Clinical Care Options (*)|Other relevant financial or material interests-Curio Science, LLC (*)|Other relevant financial or material interests-Eli Lilly & Co (*)|Other relevant financial or material interests-Elsevier Inc (*)|Other relevant financial or material interests-F Hoffmann (Relationship has ended)|Other relevant financial or material interests-Genentech Inc|Speakers Bureau-MJH Live Events (*)|Other relevant financial or material interests-Not Found (*)|Other relevant financial or material interests-Nurix Therapeutics (*)|Other relevant financial or material interests-Octapharma USA Inc (*)|Speakers Bureau-Research To Practice (*)|Grant or research support-Loxo Oncology|Grant or research support-BeOne Medicines (formerly BeiGene Ltd)|Grant or research support-AstraZeneca Pharmaceuticals LP|Grant or research support-Genentech Inc|Other relevant financial or material interests-AbbVie Inc|Other relevant financial or material interests-Aptitude Health (*)

Giulia Eva Maria Petrone, MD
Assistant Professor
WashU Medicine
St. Louis, MO

Faculty

Nothing to disclose

David A Russler-Germain, MD
Instructor of Medicine in Oncology
WashU Medicine
St. Louis, MO

Faculty

Other relevant financial or material interests-AbbVie Inc (*)|Other relevant financial or material interests-Ipsen Biopharmaceuticals Inc (*)|Other relevant financial or material interests-Regeneron Pharmaceuticals (*)|Grant or research support-Genentech Inc|Grant or research support-Tempus|Grant or research support-City of Hope

Kristen Marie M. Sanfilippo, MD, MPHS
Associate Professor of Medicine, Division of Hematology
WashU Medicine
St. Louis, MO

Faculty

Michael Slade, MD
Assistant Professor of Medicine Division of Oncology, Leukemia and Bone Marrow Transplant
WashU Medicine
St. Louis, MO

Faculty

Grant or research support-AbbVie Inc|Grant or research support-AstraZeneca Pharmaceuticals LP|Grant or research support-BeOne Medicines (formerly BeiGene Ltd)|Grant or research support-Bristol Myers Squibb Co/BMS|Grant or research support-Celgene Corporation|Grant or research support-CellCentric|Grant or research support-Cures Within Reach|Grant or research support-Genentech Inc|Grant or research support-Menarini Silicon Biosystems|Grant or research support-Multiple Myeloma Research Consortium, LLC|Grant or research support-Natera, Inc.|Grant or research support-NeoImmuneTech|Grant or research support-Pfizer Inc|Grant or research support-Phase Genomics|Grant or research support-Sanofi US Services Inc|Speakers Bureau-Curio (*)|Speakers Bureau-Roche Bioscience (*)

Samuel Urrutia, MD, MS
Assistant Professor of Medicine Division of Oncology
WashU Medicine
St. Louis, MO

Faculty

Grant or research support-AbbVie Inc|Grant or research support-Ascentage Pharma|Grant or research support-BEAT AML LLC|Grant or research support-Gamida Cell|Grant or research support-Janssen Research & Development LLC|Grant or research support-Rigel Pharmaceuticals Inc|Other relevant financial or material interests

Amy W. Zhou, MD
Associate Professor of Medicine Division of Hematology
WashU Medicine
St. Louis, MO

Faculty

Speakers Bureau-Aptitude Health (*)|Other relevant financial or material interests-Incyte Corporation (*)|Speakers Bureau-MJH Life Sciences (*)|Other relevant financial or material interests-PharmaEssentia Corporation (*)|Other relevant financial or material interests-Takeda Pharmaceuticals USA Inc (*)|Grant or research support-Sumitomo Pharma Oncology Inc|Grant or research support-Rigel Pharmaceuticals Inc|Grant or research support-Phoenix Molecular Designs

Holly S. Comer, NP, ANP-BC
Nurse Practitioner Section Outpatient Hematologic Malignancies
WashU Medicine
St. Louis, MO

Faculty, Nurse Planner

Nothing to disclose

Lindsay Hladnik, PharmD, BCOP
Outpatient Hematologic Malignancies/Stem Cell Transplant Clinical Pharmacy Specialist
Barnes-Jewish Hospital/WashU Medicine
St. Louis, MO

Faculty, Pharmacy Planner

Nothing to disclose

Saturday, January 16, 2027

If you are with a company and would like to exhibit or provide an educational grant for this educational program, please contact Stacy Partrich at [email protected] 

*** IMPORTANT NOTE for Employees of industry (e.g., pharmaceutical & device companies): DO NOT REGISTER ONLINE. Please email [email protected] for pre-approval for attendance at this course. Should you register without pre-approval, your registration will be cancelled and refunded less a $25 administrative fee.